Literature DB >> 11137643

Quality measures of antimicrobial drug use.

I C Gyssens1.   

Abstract

Antimicrobial use is the major determinant in the development of resistance. Many parameters of importance for optimal quality of antimicrobial therapy have already been defined. Maximal efficacy of the treatment should be combined with minimal toxicity at the lowest cost. Quality of antimicrobial drug use is dependent on knowledge of many aspects of infectious diseases. Considering efficacy, many of our indications for antimicrobial use need critical evaluation. Irrational use should be discouraged. Avoidance of the development of resistance is a quality parameter that will need increasing attention. This paper reviews the well-established factors that may influence the appropriateness of pharmacotherapy with antimicrobial drugs. It cites recent evidence supporting principles of prudent prescribing and gives an overview of audits that have addressed these parameters. Measures relating to resistance are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137643     DOI: 10.1016/s0924-8579(00)00208-9

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  17 in total

1.  A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use.

Authors:  Mamoon A Aldeyab; Mary P Kearney; James C McElnay; Fidelma A Magee; Geraldine Conlon; Dianne Gill; Peter Davey; Arno Muller; Herman Goossens; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.

Authors:  Peter G M Mol; Petra Denig; Rijk O B Gans; Prashant V Nannanpanday; John E Degener; Marian Laseur; Flora M Haaijer-Ruskamp
Journal:  Eur J Clin Pharmacol       Date:  2006-01-24       Impact factor: 2.953

3.  Knowledge, attitudes and behavior regarding antibiotics use and misuse among adults in the community of Jordan. A pilot study.

Authors:  Mayadah Shehadeh; Ghadeer Suaifan; Rula M Darwish; Mayyada Wazaify; Luna Zaru; Suzan Alja'fari
Journal:  Saudi Pharm J       Date:  2011-12-02       Impact factor: 4.330

4.  Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey.

Authors:  C Vercheval; M Gillet; N Maes; A Albert; F Frippiat; P Damas; T Van Hees
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-02       Impact factor: 3.267

5.  SCC mec typing and antimicrobial resistance of methicillin-resistant Staphylococcus aureus (MRSA) from pigs of Northeast India.

Authors:  S Rajkhowa; D K Sarma; S R Pegu
Journal:  Vet Res Commun       Date:  2016-07-23       Impact factor: 2.459

6.  Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey.

Authors:  Alexia Cusini; Silvana K Rampini; Vineeta Bansal; Bruno Ledergerber; Stefan P Kuster; Christian Ruef; Rainer Weber
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

7.  Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units.

Authors:  Philippe Montravers; Hervé Dupont; Rémy Gauzit; Benoit Veber; Jean-Pierre Bedos; Alain Lepape
Journal:  Crit Care       Date:  2011-01-13       Impact factor: 9.097

8.  Evaluation of antibiotic prescription in the Lebanese community: a pilot study.

Authors:  Nadine Saleh; Sanaa Awada; Rana Awwad; Sahar Jibai; Chadi Arfoul; Liliana Zaiter; Wissam Dib; Pascale Salameh
Journal:  Infect Ecol Epidemiol       Date:  2015-06-24

9.  Evaluation of rational use of veterinary drugs especially antimicrobials and anthelmintics in Bishoftu, Central Ethiopia.

Authors:  Takele Beyene; Dagnachew Endalamaw; Yonas Tolossa; Ashenafi Feyisa
Journal:  BMC Res Notes       Date:  2015-09-28

Review 10.  A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies.

Authors:  Annelie A Monnier; Evelina Tacconelli; Christine Årdal; Marco Cavaleri; Inge C Gyssens
Journal:  JAC Antimicrob Resist       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.